Samira Bell
About
Samira Bell is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine.
According to data from OpenAlex, Samira Bell has authored 78 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Nephrology, 14 papers in Cardiology and Cardiovascular Medicine and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Samira Bell's work include Acute Kidney Injury Research (31 papers), Chronic Kidney Disease and Diabetes (21 papers) and Dialysis and Renal Disease Management (10 papers). Samira Bell is often cited by papers focused on Acute Kidney Injury Research (31 papers), Chronic Kidney Disease and Diabetes (21 papers) and Dialysis and Renal Disease Management (10 papers). Samira Bell collaborates with scholars based in United Kingdom, United States and Canada. Samira Bell's co-authors include Bruce Guthrie, Peter T. Donnan, Charis Marwick, Xinyu Zhang, Jay L. Koyner, Lui G. Forni, Michael Joannidis, Matthieu Legrand, Vincenzo Cantaluppi and Kathleen D. Liu and has published in prestigious journals such as Journal of the American College of Cardiology, Cochrane Database of Systematic Reviews and Kidney International.
In The Last Decade
Samira Bell
73 papers receiving 1.9k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Samira Bell United Kingdom | 22 | 791 | 363 | 339 | 274 | 222 | 78 | 1.9k | ||
| Geetha Maddukuri United States | 11 | 522 0.7× | 211 0.6× | 246 0.7× | 155 0.6× | 200 0.9× | 14 | 1.5k | ||
| Kearkiat Praditpornsilpa Thailand | 28 | 1.1k 1.4× | 220 0.6× | 404 1.2× | 170 0.6× | 247 1.1× | 176 | 2.7k | ||
| Gregory L. Braden United States | 23 | 928 1.2× | 294 0.8× | 400 1.2× | 296 1.1× | 908 4.1× | 91 | 2.5k | ||
| Laurie A. Tomlinson United Kingdom | 30 | 1.2k 1.5× | 331 0.9× | 360 1.1× | 861 3.1× | 463 2.1× | 115 | 2.9k | ||
| Ji‐Young Choi South Korea | 25 | 802 1.0× | 238 0.7× | 340 1.0× | 103 0.4× | 212 1.0× | 157 | 2.0k | ||
| Mary T. Brophy United States | 28 | 789 1.0× | 177 0.5× | 418 1.2× | 986 3.6× | 436 2.0× | 114 | 3.3k | ||
| Javier A. Neyra United States | 28 | 1.7k 2.2× | 153 0.4× | 559 1.6× | 334 1.2× | 334 1.5× | 163 | 2.7k | ||
| José António Lopes Portugal | 25 | 1.2k 1.5× | 167 0.5× | 498 1.5× | 340 1.2× | 273 1.2× | 95 | 2.0k | ||
| Patricia de Sequera Spain | 18 | 742 0.9× | 124 0.3× | 187 0.6× | 229 0.8× | 185 0.8× | 100 | 1.6k | ||
| Frieder Keller Germany | 29 | 839 1.1× | 266 0.7× | 431 1.3× | 169 0.6× | 418 1.9× | 160 | 2.8k |
Countries citing papers authored by Samira Bell
Since
Specialization
Citations
This map shows the geographic impact of Samira Bell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samira Bell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samira Bell more than expected).
Fields of papers citing papers by Samira Bell
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Samira Bell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samira Bell. The network helps show where Samira Bell may publish in the future.
Co-authorship network of co-authors of Samira Bell
This figure shows the co-authorship network connecting the top 25 collaborators of Samira Bell. A scholar is included among the top collaborators of Samira Bell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samira Bell. Samira Bell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Geddes, Colin, Samira Bell, Bryan R. Conway, et al.. (2025). Major complications of percutaneous native and transplant kidney biopsy: a complete 10-year national prospective cohort study. Clinical Kidney Journal. 18(7). sfaf196–sfaf196.
2.
Bell, Samira, et al.. (2025). Obesity and Chronic Kidney Disease: The Dual Epidemic in Cardiovascular Health. European Cardiology Review. 20. e28–e28.
3.
Quint, Jennifer K, Sabada Dube, Lucy Carty, et al.. (2025). Immunocompromised individuals remain at risk of COVID-19: 2023 results from the observational INFORM study. Journal of Infection. 90(3). 106432–106432.
4.
Walker, Heather, et al.. (2025). Multimorbidity and analgesic-related harms: a systematic review. British Journal of Anaesthesia. 134(6). 1717–1745.
5.
Fu, Edouard L., Stuart J. McGurnaghan, Bryan R. Conway, et al.. (2024). Stopping Versus Continuing Metformin in Patients With Advanced CKD: A Nationwide Scottish Target Trial Emulation Study. American Journal of Kidney Diseases. 85(2). 196–204.e1.
6.
Lam, Jie Min, Jehad Abdalla, Samira Bell, et al.. (2024). Immunobridging Trials: An Important Tool to Protect Vulnerable and Immunocompromised Patients Against Evolving Pathogens. Vaccines. 13(1). 19–19.
7.
Sawhney, Simon, Samira Bell, Corri Black, et al.. (2023). Recovery of kidney function after acute kidney disease—a multi-cohort analysis. Nephrology Dialysis Transplantation. 39(3). 426–435.
8.
Evans, Rachael A, Sabada Dube, Yi Lu, et al.. (2023). Impact of COVID-19 on immunocompromised populations during the Omicron era: insights from the observational population-based INFORM study. The Lancet Regional Health - Europe. 35. 100747–100747.
9.
Gallacher, Peter J., Robert W. Hunter, Moneeza K. Siddiqui, et al.. (2022). Cardiovascular outcomes in patients with chronic kidney disease and COVID-19: a multi-regional data-linkage study. European Respiratory Journal. 60(5). 2103168–2103168.
10.
Gao, Chuang, Samira Bell, Ify Mordi, et al.. (2022). PRE-PROCEDURAL RISK SCORES TO HELP IDENTIFY PATIENTS AT RISK OF CONTRAST INDUCED NEPHROPATHY AFTER CHRONIC TOTAL OCCLUSION PERCUTANEOUS CORONARY INTERVENTION FOR PERI-PROCEDURAL NEPHROPROTECTIVE THERAPIES. Journal of the American College of Cardiology. 79(9). 842–842.
11.
Sawhney, Simon, Samira Bell, Corri Black, et al.. (2022). Harmonization of epidemiology of acute kidney injury and acute kidney disease produces comparable findings across four geographic populations. Kidney International. 101(6). 1271–1281.
12.
Parcell, Benjamin J., et al.. (2021). The association between SARS-CoV-2 RT-PCR cycle threshold and mortality in a community cohort. European Respiratory Journal. 58(1). 2100360–2100360.
13.
Zhang, Xinyu, Peter T. Donnan, Samira Bell, & Bruce Guthrie. (2017). Non-steroidal anti-inflammatory drug induced acute kidney injury in the community dwelling general population and people with chronic kidney disease: systematic review and meta-analysis. BMC Nephrology. 18(1). 256–256.
14.
Patton, Andrea, et al.. (2016). Incidence and Outcomes of Acute Kidney Injury Requiring Renal Replacement Therapy: A Retrospective Cohort Study. The Nephron journals/Nephron journals. 133(4). 239–246.
15.
Dreischulte, Tobias, Daniel R. Morales, Samira Bell, & Bruce Guthrie. (2015). Combined use of nonsteroidal anti-inflammatory drugs with diuretics and/or renin–angiotensin system inhibitors in the community increases the risk of acute kidney injury. Kidney International. 88(2). 396–403.
16.
Bell, Samira, Friedo W. Dekker, Thenmalar Vadiveloo, et al.. (2015). Risk of postoperative acute kidney injury in patients undergoing orthopaedic surgery--development and validation of a risk score and effect of acute kidney injury on survival: observational cohort study. BMJ. 351(nov11 19). h5639–h5639.
17.
Bell, Samira, et al.. (2014). Effects of peri-operative nonsteroidal anti-inflammatory drugs on postoperative kidney function for adults with normal kidney function. Cochrane Database of Systematic Reviews. 11. CD011274–CD011274.
18.
Campbell‐Scherer, Denise, Julia H. Rogers, Donna Manca, et al.. (2014). Guideline harmonization and implementation plan for the BETTER trial: Building on Existing Tools to Improve Chronic Disease Prevention and Screening in Family Practice. CMAJ Open. 2(1). E1–E10.
19.
Jennings, Claudine G., J. Graeme Houston, Alison Severn, et al.. (2014). Renal Artery Stenosis—When To Screen, What To Stent?. Current Atherosclerosis Reports. 16(6). 416–416.
20.
Bell, Samira, Josephine Cooney, Christopher J. Packard, Muriel Caslake, & Christopher J. Deighan. (2008). Omega-3 fatty acids improve postprandial lipaemia in patients with nephrotic range proteinuria. Atherosclerosis. 205(1). 296–301.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Geetha Maddukuri Breakdown of academic impact, for papers by Kearkiat Praditpornsilpa Breakdown of academic impact, for papers by Gregory L. Braden Breakdown of academic impact, for papers by Laurie A. Tomlinson Breakdown of academic impact, for papers by Ji‐Young Choi Breakdown of academic impact, for papers by Mary T. Brophy Breakdown of academic impact, for papers by Javier A. Neyra Breakdown of academic impact, for papers by José António Lopes Breakdown of academic impact, for papers by Patricia de Sequera Breakdown of academic impact, for papers by Frieder Keller